Cancer Drug

The bacterial vaccine proved to be particularly more efficacious than peptide-based therapeutic cancer vaccines

The Union minister also brought down the customs duty on X-ray tubes used in medical X-ray machines

Manufacturer AstraZeneca Pharma India says its study shows drug may have detrimental effect

The U.S. Food and Drug Administration's accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients' lives? In a new study, researchers found that most cancer drugs granted accelerated approval do not demonstrate such benefits within five years. Five years after the initial accelerated approval, you should have a definitive answer, said Dr. Ezekiel Emanuel, a cancer specialist and bioethicist at the University of Pennsylvania who was not involved in the research. Thousands of people are getting those drugs. That seems a mistake if we don't know whether they work or not." The program was created in 1992 to speed access to HIV drugs. Today, 85% of accelerated approvals go to cancer drugs. It allows the FDA to grant early approval to drugs that show promising initial results for treating debilitating or fatal diseases. In exchange, drug companies are expected to do rigorous testing and produce

This new pill will reduce the side effects of cancer treatment like chemotherapy by about 50 per cent and the chances of getting cancer for a second time by 30 per cent

The company's product is therapeutically equivalent to AstraZeneca UK's Calquence Capsules (100 mg)

Lupin on Monday said it has received a tentative approval from the US health regulator to market Dasatinib tablets, used to treat certain types of cancer, in America. The company in partnership with Pharmascience Inc. has received approval from the US Food and Drug Administration (FDA) for Dasatinib tablets in strengths of 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, it said in a statement. The Mumbai-based drug maker's product is a generic version of Bristol-Myers Squibb Company's Sprycel tablets. As per IQVIA MAT data, Dasatinib tablets had an estimated annual sale of USD 1,569 million in the US. Shares of Lupin settled at Rs 662.50 apiece, up 1.49 per cent on the BSE.

Drug firm Zydus Cadila on Wednesday said it has received tentative approval from the US health regulator to market Ibrutinib tablets used in the treatment of certain types of cancers.

As it takes away the legal overhang, Cipla can launch the drug once its ANDA is approved

The UK drugmaker will pay Japan's Daiichi $1 billion upfront to jointly develop and bring to market a cancer therapy in early clinical tests called DS-1062, the companies said

US company Blueprint, which has been working with Roche since 2016, could also receive up to $927 million in milestone payments, plus royalties on sales outside the United States

The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson

The study has found that the environment plays a statistically significant role in outcomes of cancers like acute leukaemia which need intensive treatment

It determined that people in poorer nations were on average 2.5 times more likely to die from heart disease than those in richer ones

The complex biological medicines, called antibody drug conjugates (ADCs), have been in development for decades

All companies have been asked to ensure that the price caps are adhered to.

This move is expected to benefit 22 lakh cancer patients in the country and would result in annual savings of around Rs 800 crore to the patients

However, it is not yet clear whether China has agreed to grant licences to Indian companies to sell cancer drug in the huge market

It is estimated that every year over 700,000 patients die due to various types of cancer in India

The single judge had also refused to revoke the patent of the Swiss company as sought by Cipla